Orphan Drug Development

Orphan Drug Development
Product Description

Accelerating orphan drug development from candidate selection to commercial manufacture and supply.

With over 300 million people worldwide living with identified rare diseases, the development of new treatments to address these unmet clinical needs is an area of great interest in the pharmaceutical industry.

Despite improvements in regulatory support and commercial rewards for developing orphan drugs, difficulties remain for drug developers in bringing these medicines to market quickly; including limited R&D budgets, alongside an ever-evolving regulatory framework, challenging product development and clinical recruitment.

- Integrated capabilities and expertise- Pre-formulation and API characterisation
- Formulation and process development
- First-in-human clinical testing and acceleration into POC trials
- Bespoke clinical manufacturing and supply (Phase I-III) of drug products into patient trials
- Rapid scale-up and commercial manufacturing of low-volume products

QUOTIENT SCIENCES LIMITED

  • GB
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Academic/Research
Consultancy
Contract Service
Manufacturer/Innovator
Specifications
  • Supplied from
    United Kingdom; United States

QUOTIENT SCIENCES LIMITED

  • GB
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Academic/Research
Consultancy
Contract Service
Manufacturer/Innovator

More Products from QUOTIENT SCIENCES LIMITED (16)

  • Clinical Pharmacology

    Product Clinical Pharmacology

    When you are looking for a partner who is dedicated to Phase I trials and early clinical development, rely on Quotient Sciences for the experience and expertise to seamlessly deliver your studies with the highest quality service and speed. We accelerate your molecule from first-in-human to proof-of-concept...
  • Bioanaysis

    Product Bioanaysis

    Delivering rapid bioanalytical data in discovery – preclinical – clinical. Bioanalysis is a critical step in the drug development process.  At Quotient, we are experts in the development, validation, and application of bioanalytical assays.  
    Our dedicated team of bioanalytical chemists...
  • Data Sciences

    Product Data Sciences

    You need data rapidly to make crucial decisions during a study. Faster data means we can provide our customers with earlier interim data and interim PK reports for on-study dosing and formulation decisions.
    We understand on-study changes to early phase study designs and d...
  • Drug Development Consulting

    Product Drug Development Consulting

    Our Drug Development Consultants work with you to design and implement successful drug development programs. With industry leading scientific expertise across a range of technical disciplines, we help customers across all stages of development, from candidate selection to commercial launch.

    Our cons...
  • Global Clinical Trial Supply

    Product Global Clinical Trial Supply

    Accelerate your timeline, with flexible, on-demand delivery. We’ll design and develop your packaging, labelling and distribution strategy for Phase I, Phase II and Phase III clinical studies, so you’ll no longer have to worry about the challenge of getting your drug product to multiple sites in time fo...
  • Pediatric Development

    Product Pediatric Development

    Pediatric formulation and product development

    The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements. Quotient Sciences has extensive knowledge and capabilities that enable us to provide you...
  • Inhaled Drug Development

    Product Inhaled Drug Development

    Quotient has a 30 year track record in the development and manufacturing of inhaled drug products. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation. With integrated capabilities and vast knowledge of nasal and pu...
  • Translational Pharmaceutics - Integrated Programs

    Product Translational Pharmaceutics - Integrated Programs

    Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs. qq...
  • Oncology

    Product Oncology


    Supporting oncology drug development from candidate selection through to commercial manufacture and supply
    In the past 5 years alone, Quotient has successfully worked on over 300 oncology development projects for 91 different oncology drug candidates spanning 34 different disea...
  • Candidate Selection - Integrated Programs

    Product Candidate Selection - Integrated Programs

    Selecting the right molecules for development - Quickly identify the best drug candidates. Knowing what it takes to develop a successful drug, we help clients select the best molecules for development. Our unique integration of scientific capabilities enables us to provide a complete assessment o...
  • Early Stage Development - Integrated Programs

    Product Early Stage Development - Integrated Programs

    Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabil...
  • Late Stage Development - Integrated Programs

    Product Late Stage Development - Integrated Programs

    .Accelerating products through to commercial manufacture - Speed the journey from proof-of-concept to commercial launch. The journey from proof-of-concept to commercial launch can be complex. Speed is critical but it shouldn’t come at the expense of product quality. Creating patient-centric formulatio...

QUOTIENT SCIENCES LIMITED resources (25)

  • News CPHI Milan 2024: Excerpts from the Exhibitors

    After another successful year of bringing the pharmaceutical community together at CPHI Milan in October, hear direct from the exhibitors on why the event is so important for them and the industry as a whole. 
  • Datasheet Formulation Development at Quotient

    Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development. 
  • News Quotient Sciences acquires UK-based CDMO Arcinova

    With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide
  • Datasheet Clinical Pharmacology at Quotient

    When you are looking for a partner who is dedicated to Phase I trials and early development,rely on Quotient Sciences. 

    We accelerate your molecule from first-in-human to proof-of-concept,helping you make critical decisions earlier. 
    Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.
  • News Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic

    Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical pharmacology facility. 


    The expanded pharmacy capabilities offer customers a quick and cost-effective way to start clinical testing, without the need for extensive CMC investment or API consumption at this early stage of development.
  • Datasheet Global Formulation & Manufacturing Capabilities

    With over 30 years’ experience, Quotient Sciences provides full service support for small molecule non-sterile programs, from dosage formulation development through to GMP clinical trial manufacturing and commercial drug product supply.
  • News Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm

    Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc. a privately help biotechnology company focused on the development of pharmaceutical products for treatment of infectious diseases.
  • Datasheet Clinical Trial Manufacturing at Quotient

    Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient offers a clinical trial manufacturing, testing and certification service designed to meet your individual requirements. 

    Our innovative method of building integrated GMP and GCP programs provides you with a streamlined, flexible approach to drug product supply that reflects your clinical study design and timeline. 


    We understand the time and cost pressures you face during early phase evaluation and work with you to ensure a rapid, seamless path from development to clinical trial supply.
  • News ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19 Collaboration

    ANA Therapeutics, a Silicon Valley-based biotech startup, and Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19.
  • Datasheet Commercial Manufacturing at Quotient

    Pharmaceutical commercial manufacturing - Quotient Sciences is a global player in commercial drug product manufacture of small molecule products for niche therapies including oncology and orphan drugs. 
    Our commercial manufacturing facility located in Philadelphia is designed to handle your high-potency compounds.
  • Datasheet Pediatric Development at Quotient

    Pediatric formulation and product development
    The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements. 

    Quotient Sciences has extensive knowledge and capabilities that enable us to provide you with a unique integrated pediatric development solution.

  • Datasheet Taste Masking at Quotient

    Many drug substances are extremely bitter or have other aversive attributes,which can make developing palatable drug products extremely challenging.This is a common problem seen in medicines spanning all therapeutic areas,from antibiotics and painkillers to antihistamines and decongestants. The careful design and development of formulated oral drug products is key to ensuring patient acceptability and compliance for achieving the desired clinical outcomes.
  • Datasheet 505(b)(2) Product Development at Quotient

    Are you developing a new dosage form for an existing drug? 

    Do you need to explore a different route of administration?

    Quotient has significant experience in 505(b)(2)product development and can support you in efficiently turning your innovative ideas into successful products.Over the past several years, the FDA’s 505(b)(2)regulatory pathway has enabled the approval of a variety of differentiated dosage forms for existing molecules
  • Datasheet Translational Pharmaceutics - a Quotient Innovation

    Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs.
  • Datasheet PBPK Modelling and Simulation at Quotient

    Quotient is a leading expert in the application of physiologically based pharmacokinetic (PBPK) modelling and simulation (M&S) science to drug development. 

    Using GastroPlus™ we advise our clients on the potential in vivo performance of drugs and formulations to inform product and clinical development strategies. 


    Whether working in a consultancy relationship or as part of an integrated program of work, our PBPK expertise is underpinned by our unique and extensive experience in pharmaceutics, biopharmaceutics, DMPK and clinical research.
  • Datasheet Pre-formulation & Material Sciences at Quotient

    Providing expertise to support pre-formulation development

    Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
  • Datasheet Compounding and GMP Manufacturing for Product Supply at Quotient

    Quotient Sciences provides integrated pharmacy compounding, formulation, GMP manufacturing and clinical testing solutions to help clients achieve their proof-of-concept (POC) milestone quickly, saving them precious development time and money.  

    Begin your First-in-Human (FIH) Phase I testing with a fit-for-purpose, simple pharmacy preparation, and then seamlessly transition to a scalable, solid oral GMP drug product for Phase II trials, all within one organization.
  • Datasheet Inhaled Product Development at Quotient

    With more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept. 

    Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
  • Datasheet High Potency Handling at Quotient

    High Potency Drug Development & Manufacturing

    Highly potent active pharmaceutical ingredients (HPAPIs) are becoming increasingly common in drug development pipelines, especially in the oncology sector, as researchers search for therapies with greater selectivity and pharmacological activity. However, HPAPIs present additional CMC challenges due to the containment requirements to protect both the operators and manufacturing facilities. Their production processes may also require greater precision and control due to the very small quantities of drug present in the final dosage form.
  • Datasheet Human ADME Studies at Quotient

    Whatever your requirements, Quotient Sciences can support you in the generation of clinical metabolism data for your drug development program and for NDA, MAA and global regulatory filings.
  • Datasheet First-in-human to Proof-of-Concept at Quotient

    Quotient Sciences’ Translational Pharmaceutics® approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.

    How? Quotient’s Translational Pharmaceutics® platform integrates formulation development, real-time adaptive GMP manufacturing and clinical testing so that drug product manufacture occurs immediately prior to dosing.Each manufacture of drug product is therefore conducted in response to emerging clinical data. This approach delivers significant benefits to the development team.
  • Datasheet Spray Drying at Quotient

    Overcoming poor drug solubility and bioavailability challenges

    Drug solubility has a significant impact on bioavailability. 70% of new chemical entities (NCEs) suffer from low aqueous solubility that can result in failure during clinical testing due to poor bioavailability. Selecting an appropriate drug formulation is imperative to the success of the program.
  • Datasheet Project Management at Quotient

    Project Management at Quotient – A True Partnership
    Quotient is an innovative drug development and manufacturing partner supporting clients from candidate selection to commercial launch. With expertise in end-to-end Project Management and integrated project teams, we make drug development easier for our customers and dramatically reduce the time and cost of getting new medicines to patients.
  • Video John McDermott, Quotient Sciences, discusses the unique benefits of Translational Pharmaceutics

    John McDermott, Executive Director, Drug Development Solutions - Quotient Sciences discusses Translational Pharmaceutics at CPHI Worldwide, and how a recent Tufts study has proven the significant savings and financial benefits for drug developers who use Translational Pharmaceutics.
  • Datasheet Formulation Strategies for Poorly Soluble Molecules at Quotient

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation. Scientists will need to utilize advanced formulation technologies to maximize oral bioavailability.

Frequently Viewed Together

  • Product Formulation Development

    Recipharm offer formulation development services for all dosage forms. We develop everything from simple formulations for early studies to more complex formulations suited for commercialisation.
  • Product Cosmetic Ampoules

    Skin ampoules are the latest top trend. Single-dose with a high concentration of active ingredients, they work an instant effect on the skin. The volume chosen is ideal for using half the ampoule in the morning and half at night. They must always be applied to clean skin, and can be spread by gently m...
  • Product Functional film coating

    Easy, fast and reliable enteric protection? Why not! - High performance protection against acidic conditions. - Suitable for granules, pellets, tablets and capsules. - For pharmaceutical and nutraceutical applications.
  • Product CRO and CDMO Solutions

    CRO and CDMO solutions: Transforming the pharmaceutical value chain for emerging biotechs and large pharmas - How integrating research and manufacturing processes enhances efficiency and accelerates time to market.
  • Product CONTRACT MANUFACTURING - SMALL MOLECULES

    KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance allow us to become your preferred CDMO solutions partner.

    Your Agile Experts
    • Responsive to our customers’ needs in a more dynamic customer-centric way • Adaptive to the most diverse re...
  • Product Pulmonary Delivery

    Where particle size and performance really matters, Upperton have the expertise.
    Drug delivery into the lung is one of the fastest growing, yet technically challenging areas of pharmaceutical development. Producing a successful pulmonary drug product requires expertise in formulation development, part...
  • Product Analytical Development:

    •Development and validation of analytical methods to ensure accurate quantification, purity assessment, and impurity profiling. 

    •Characterization of raw materials, intermediates, and final APIs using techniques such as HPLC, GC, MS, NMR, and XRPD. 

    •Stability studies and fo...
  • Product Products for livestock

    Products for livestock : oral gels, oral pastes, liquids, powders, bolus, effervescent tablets ... filled in specific packaging according to species, product, dosage, use : plastic bottle, aluminium pouch, bag, bucket // Compliant to EU regulation
  • Product OTF - Oral Thin Films

    Oral thin films are loaded with active substances. The Thin films are taken orally and dissolve immediately in the mouth or are applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal ...
  • Product Inhalation Test Services

    We are the world’s leading provider of orally inhaled and nasal drug product design and development services. We enable the seamless translation of pre-clinical development through to clinical manufacture of OINDPs. We do this through our unique processing technologies and formulation development tools....
  • Product tiny-TIMsg

    The tiny-TIMsg system, as part of the SurroGUT™ platform, precisely mimics the upper GI tract and all physiologically relevant processes; including the pressure, shear forces and phase specific gastric emptying. The tiny-TIMsg consists of an advanced gastric compartment (TIMagc) and small intestine co...
  • Product Complex Semi-synthetic APIs

    Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.
  • Product GCP Services(Good Clinical Practices)

    We offer various GCP services which can help the clients across globe, ranging from audits to monitoring services. We provide comprehensive GCP Quality Compliance services to the pharmaceutical industry. Our GCP consulting services are characterized by:

    1) Knowledge: Various regulatory requi...
  • Product Stratµm™ Technology for Injectable Delivery

    The Stratµm™ technology, for injectable delivery, allows for precise control of particle size and composition enabling predictable injectable performance, which is critical for self-administration, extended release, and modified release applications with a narrow therapeutic index. Unlike other encapsu...
  • Product Analytical research & development

    Our analytical experts know what it takes to bring a pharmaceutical product to the market, from discovery, feasibility to GMP. Having worked with more than 100 unique molecules and even more formulations, we may state that we have faced the most difficult CMC challenges that are involved.
    ...
  • Product Custom Protein Synthesis

    We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
  • Product SERVICES

    With a wide range of new customer services, you will find in RENOLIT Healthcare a strong partner with innovative and customised full-service solutions to meet your specific challenges.

    Whether as part of a joint venture or in the form of a partnership - as a service partner RENOLIT Healthcare provid...
  • Product Integrated Services

    Huayi Pharmaceuticals offers an integrated service for product development with our partners Weida Clinical Research and Velocyte Analytical Technology for your bioequivalence needs in China. Through these close strategic partnerships, we are able to offer a one-stop service which allows pharmaceutical dev...
  • Product UniLayer - 200mg Paracetamol

    This product is suitable for children and adults, as a delivery system when taking this medication. 

    Must be taken with water or beverage of choice. 

    We are looking for partner on a CDMO bases. 
  • Product ENNA MOISTURIZING GEL VAGINAL DRYNESS

    ENNA MOISTURIZING GEL AGAINST VAGINAL DRYNESS. MEDICAL DEVICE. VEGAN. CLINICALLY AND GYNECOLOGICALLY TESTED
  • Product Clinical Research Solutions

    We design and execute clinical trials so new therapies get to market in the quickest and safest way possible. Full-Service Solution: We manage and execute full-service clinical trials across major therapeutic areas within medical device, diagnostics, drug, and biologic. Functional Service Provisi...
  • Product Exemestane

    CTD-DMF, CEP & USDMF
  • Product Formulation Development

    The NUVISAN formulation group up has a proven heritage of effective product development with team members being responsible for the creation of topical formulas that supported several commercially successful products. These successes were underpinned by our focus on innovation and patient and health care p...
  • Product DIDN'T FIND WHAT YOU WERE LOOKING FOR?

    We are an high level outsourcing partner: from design to finished product manufacture, you can rely on our expertise to bring your own product on the market.

    Tell us what you were looking for and we will be more than happy to help you!


    Contact us!

  • Product BDD Scintigraphy

    Gamma scintigraphy is a powerful and versatile technology used to investigate the in-vivo performance of your drug or product. This non-invasive imaging technique allows us to follow the fate of the dosage form and administering it to a volunteer or patient. Not limited to just oral dosage forms, gamma sci...
  • Product Formulation Development

    Formulation & process development of complex oral solids drug products. Specialized in solubility enhancement, drug delivery, controlled release, functional coating, granulation, pellets & micropellets. From technical feasibility to GMP for clinical trials and commercial manufacturing.Core compente...
  • Product Biocompatibility of Medical Devices according to ISO 10993-1 series

    Galileo Research can drive the nonclinical development of your medical device by preparing the Literature Report and the Biological Evaluation Plan (BEP) according to ISO 10993-1, performing additional tests, if needed, and releasing the Biological Evaluation Report (BER).

    All tests can be condu...
  • Product R&D Services

    Our R&D Services are categorized into 8 streams: • Material Science Services

    • Metal and Organic Scavenging Screening Services

    • Organic Synthesis Services

    • Catalysis Services

    • Process Services

    • Chromatography and Purification Services

    • Method D...
  • Product Fourier PAT

    We celebrate the arrival of our synTQ by Optimal NMR adapter – opening the door to a new world of PAT for the Bruker Fourier 80. This brings a wealth of structural information and direct quantification to online chemical and bioprocess monitoring, resulting in further reductions in risk and cost.
  • Product Clinical Manufacturing

    KBI Biopharma offers a broad range of cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Our capabilities include reliable manufacturing for preclinical and clinical supply.

    KBI’s experienced team produces high-quality therapeutics and vaccines thro...
  • Product Inhaled Formulation Development

    With expertise in powder and liquid formulations for small molecules and biologics, as well as a broad portfolio of proprietary device and formulation technologies, we can help you overcome the challenges of inhaled formulation development.

    Dry Powder Formulation
    Advanced po...
  • Product Cell-based Neutralization Assays

    Experienced cell-based neutralizing antibody assay capabilities. Our experts, at our GLP/GCP compliant laboratory, evaluate each therapeutic, conduct tailored assay development and ensure that each assay is optimized to suitably determine the presence of NAb with maximum possible level of drug toleran...
  • Product R&D and Industrialization

    We specialise in research and development in the ophthalmic field for multinationals, Italian as well as international pharmaceutical companies. For them, we develop, fine-tune and manufacture, in aseptic conditions, pharmaceuticals and sterile medical devices for topical use in differen...
  • Product Research & Development of medical devices

    We provide a complete and comprehensive range of services from A to Z for substance-based  medical devices: from product idea, through development and research, certification, registration and product delivery to the customer.

    With us, you can easily launch a new substance-based ...
  • Product Finished Product Development Services

    Midas Pharma offers wide range of pharmaceutical services which includes finished product development services. It provides a complete range of services for developing and manufacturing finished drug products and we have expertise and experience to overcome challenging galenical or analytical hurdles.It in...
  • Product Hot Melt Extrusion

    To successfully develop and manufacture your polymer-based delivery systems, like implants and intra-vaginal rings, we have advanced extrusion capabilities in Malmö (Sweden) and Putnam (US Connecticut). The US site is also a center of expertise for Hot Melt Extrusion (HME).

    HME improves the bioa...
  • Product Early stage formulation Development & Process Design

    We have extensive experience in solving complex formulation challenges. Our experts can apply our extensive range of proprietary technologies for immediate (IR) and modified (MR) / sustained, slow (SR) / controlled (CR) / extended (XR, ER) / pulsed / timed release as well as enteric and gastro reten...
  • Product Dopamine Hydrochloride Injection

    Dopamine Hydrochloride Injection is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, cardiac operation, renal failure, and chronic cardiac decompensation as in congestive heart failure; the shock cannot be corre...
  • Product Clinical solutions: Trials

    Conscio's in-house clinical Unit has been operating since 2007, with more than 600 BA/BE/PK studies completed and proprietary of over 270 validated bioanalytical methods. Equipped with a 60-bed on-site clinical unit in Prague and a recently opened 36-bed unit in Ostrava, we provide comprehensive services w...
  • Product F4CL - "Fast for Commercial Launch" Platform

    When your CMC projects approach the final step to commercial approval, you need to consider how to be sure your drugs successfully reach your intended markets. 

    Regulatory agencies have different requirements and timing. Trust in the right partner so you don’t need to worry abou...
  • Product Continuous Manufacturing of Formulations in Minutes Instead of Hours

    Microinnova Engineering GmbH has successfully commissioned two continuous formulation production plants for a European client. The design of the fully automated plant is very compact, which makes it possible to easily transport & install it at a different manufacturing site on the other side of the wor...
  • Product Pharmaceutical development (CDMO) & Exclusive portfolio

    From research, pre-formulation, and formulation development, up to commercial manufacturing  (including HPAPI).
    Bluepharma offers an integrated drug development service (CDMO) from research, pre-formulation, and formulation development, up to commercial manufacturing ...
  • Product Development Service

    Lomapharm GmbH provides wide range of services which includes development service. It provides the whole range of control services - from raw material testing to stability testing according to GMP and ICH regulations. One of the main areas of competence and experience is also available for galenic dev...
  • Product Clinical Supply Solutions Service

    Ardena offers services under brand pharmavize which includes clinical supply solutions service. It has a promising drug molecule and it is preparing for preclinical or early phase clinical studie. Its business is to develop and manage the clinical supply materials, from design to delivery. It bring the api...
  • Product Lozenges

    Our range of user-friendly dosage forms includes lozenges. Lozenges are an easy way to take medication and, with a wide range of flavorings available, there is something for everyone. Designed to dissolve or disintegrate slowly in the mouth, lozenges are capable of providing both a localized effect and a...
  • Product Custom Formulation Development

    Thépenier Pharma & Cosmetics provides bespoke formulation development services for pharmaceutical products. Teams work closely with clients to create tailored formulations that meet specific therapeutic needs and regulatory requirements. Services include initial concept development, formulation optimiz...
  • Product SAME UP

    FOOD SUPPLEMENT WITH S-ADENOSYLMETHIONINE (SAMe) AND LACTIC FERMENTS
    Helps to manage mood swings

    PRODUCT

    Our nutraceutical product helps border-line patients with predepression syndrome.
    The start of a depressive disorder is not the same as a passing blue mood. Without treatm...
  • Product Pre-Formulation Services

    A wide range of IND enabling drug product services are provided at Eurofins CDMO. Our PhD scientists have extensive experience in material characterization, analytical chemistry and strategies for developing poorly soluble compounds. Our Pre-Formulation laboratory is fitted with a suite of specialized equi...
  • Product SIMETHICONE RANGE (Gastro metabolism - Dyspepsia - Aerophagy- Infant colic)

    Simethicone is a stable mixture of silicone polymer and silicone dioxide containing anti-foaming and intestinal gas reducing properties.  It is indicated in the treatment of dyspeptic disorders and gastroenteric meteorism. Simethicone decreases the surface tension of mucus and of gas bubbles ...
  • Product Formulation Development

    MedPharm has more than 20 years’ experience developing topical and transdermal formulations. We can begin as early as API screening and support pre-formulation activities, lead formulation selection, formulation optimization and reverse engineering. We have had a role in taking over 55 products to mark...